Skip to content

Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone

Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03211338
Enrollment
115
Registered
2017-07-07
Start date
2017-07-15
Completion date
2022-06-06
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric Labor, Premature

Brief summary

The aim of this study is to investigate the In Vitro and In Vivo effect of progesterone on immature myeloid cells (IMC), inflammation characteristics and maturation into dendritic cells (DC).

Interventions

BIOLOGICALCulture with progesterone

Progesterone, a steroid hormone will be cultured with placental IMC cells or peripheral blood CD14+ monocyte cells

BIOLOGICALCulture without progesterone

Culture of placental IMC cells or peripheral blood CD14+ monocyte cells without progesterone

BIOLOGICALCulture with growth factors

Culture of placental IMC cells with growth hormones only and analysis

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Placentas from term and preterm deliveries * Singleton pregnancy * Consent to participate

Exclusion criteria

* Pregnancies with obstetric complications * Multiple gestation * Maternal illness or fetal malformation known pre-delivery

Design outcomes

Primary

MeasureTime frameDescription
Inflammation characteristic effects of progesterone on preterm and term placentasOne yearDifferences observed in cytokine profiles of IMC cells from term and preterm placentas cultured with and without progesterone
Maturation effects of progesterone on preterm and term placentasOne yearDifferences observed in maturation of IMC cells into DC cells in term and preterm placentas

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026